246 related articles for article (PubMed ID: 31427377)
1. Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.
Castle KD; Kirsch DG
Cancer Res; 2019 Nov; 79(22):5685-5692. PubMed ID: 31427377
[TBL] [Abstract][Full Text] [Related]
2. The radiobiological targets of SBRT: tumor cells or endothelial cells?
Karam SD; Bhatia S
Ann Transl Med; 2015 Nov; 3(19):290. PubMed ID: 26697450
[TBL] [Abstract][Full Text] [Related]
3. A Model of Indirect Cell Death Caused by Tumor Vascular Damage after High-Dose Radiotherapy.
Rodríguez-Barbeito P; Díaz-Botana P; Gago-Arias A; Feijoo M; Neira S; Guiu-Souto J; López-Pouso Ó; Gómez-Caamaño A; Pardo-Montero J
Cancer Res; 2019 Dec; 79(23):6044-6053. PubMed ID: 31641030
[TBL] [Abstract][Full Text] [Related]
4. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
Brown JM; Carlson DJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):254-62. PubMed ID: 24411596
[TBL] [Abstract][Full Text] [Related]
5. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
[TBL] [Abstract][Full Text] [Related]
6. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
Song CW; Glatstein E; Marks LB; Emami B; Grimm J; Sperduto PW; Kim MS; Hui S; Dusenbery KE; Cho LC
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):21-34. PubMed ID: 30836165
[TBL] [Abstract][Full Text] [Related]
7. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.
Dworzecki T; Idasiak A; Syguła D; Dworzecka U; Suwiński R
Neoplasma; 2012; 59(1):114-20. PubMed ID: 22103905
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
10. Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial.
Deodato F; Macchia G; Cilla S; Ianiro A; Sallustio G; Cammelli S; Buwenge M; Mattiucci GC; Valentini V; Morganti AG
Br J Radiol; 2019 Feb; 92(1094):20180422. PubMed ID: 30325662
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).
Park HJ; Griffin RJ; Hui S; Levitt SH; Song CW
Radiat Res; 2012 Mar; 177(3):311-27. PubMed ID: 22229487
[TBL] [Abstract][Full Text] [Related]
12. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
Wang X; Zamdborg L; Ye H; Grills IS; Yan D
BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
[TBL] [Abstract][Full Text] [Related]
14. Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis.
Sofia Vala I; Martins LR; Imaizumi N; Nunes RJ; Rino J; Kuonen F; Carvalho LM; Rüegg C; Grillo IM; Barata JT; Mareel M; Santos SC
PLoS One; 2010 Jun; 5(6):e11222. PubMed ID: 20574535
[TBL] [Abstract][Full Text] [Related]
15. Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer.
Courtney PT; Paravati AJ; Atwood TF; Raja N; Zimmerman CT; Fanta PT; Lowy AM; Simpson DR; Xu R; Murphy JD
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1003-1012. PubMed ID: 33571625
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological basis of SBRT and SRS.
Song CW; Kim MS; Cho LC; Dusenbery K; Sperduto PW
Int J Clin Oncol; 2014 Aug; 19(4):570-8. PubMed ID: 24993673
[TBL] [Abstract][Full Text] [Related]
17. Improved cellular automata model shows that indirect apoptotic cell death due to vascular damage enhances the local control of tumors by single fraction high-dose irradiation.
Kawahara D; Nagata Y; Watanabe Y
Biomed Phys Eng Express; 2021 Dec; 8(1):. PubMed ID: 34920444
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
19. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
